AnaptysBio, Inc. Names Director of Cell Biology; Joins from Regeneron Pharmaceuticals, Inc., Adds Extensive Therapeutic Antibody Discovery Credentials

SAN DIEGO--(BUSINESS WIRE)--AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced the appointment of Dr. Sean Stevens as director of cell biology.

Back to news